Beginning Cash: The amount of cash reported by the company on its previous statement.
Sinovac Biotech, Ltd. (SVA) had Beginning Cash of $1.28B for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.15B |
|
$934.61M |
|
$1.75B |
|
$12.90B |
|
$978.45M |
|
$130.32M |
|
$411.49M |
|
$1.39B |
|
$11.51B |
|
$11.50B |
|
$11.51B |
|
-- |
|
| Cash Flow Statement Financials | |
$-438.90M |
|
$436.83M |
|
$-171.18M |
|
|
Beginning Cash |
$1.28B |
$1.08B |
|
$-200.17M |
|
-- |
|
$-233.38M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|